Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $89.06 in the prior trading day, Dexcom Inc (NASDAQ: DXCM) closed at $80.77, down -9.31%. In other words, the price has decreased by -$9.31 from its previous closing price. On the day, 9.28 million shares were traded. DXCM stock price reached its highest trading level at $87.0 during the session, while it also had its lowest trading level at $80.46.
Ratios:
Our goal is to gain a better understanding of DXCM by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 10.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 55.48. For the most recent quarter (mrq), Quick Ratio is recorded 1.35 and its Current Ratio is at 1.52. In the meantime, Its Debt-to-Equity ratio is 1.00 whereas as Long-Term Debt/Eq ratio is at 0.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on June 16, 2025, initiated with a Buy rating and assigned the stock a target price of $102.
On May 30, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $104.
On April 10, 2025, Mizuho started tracking the stock assigning a Outperform rating and target price of $85.Mizuho initiated its Outperform rating on April 10, 2025, with a $85 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 28 ’25 when Stern Sadie sold 1,466 shares for $88.99 per share. The transaction valued at 130,459 led to the insider holds 106,689 shares of the business.
SADIE STERN bought 1,466 shares of DXCM for $130,459 on Jul 28 ’25. On Jul 15 ’25, another insider, FOLETTA MARK G, who serves as the Director of the company, sold 2,750 shares for $85.17 each. As a result, the insider received 234,217 and left with 53,871 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DXCM now has a Market Capitalization of 31674357760 and an Enterprise Value of 34802892800. As of this moment, Dexcom’s Price-to-Earnings (P/E) ratio for their current fiscal year is 56.55, and their Forward P/E ratio for the next fiscal year is 31.33. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.35. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.36 while its Price-to-Book (P/B) ratio in mrq is 12.31. Its current Enterprise Value per Revenue stands at 8.39 whereas that against EBITDA is 40.572.
Stock Price History:
The Beta on a monthly basis for DXCM is 1.45, which has changed by 0.11715078 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, DXCM has reached a high of $93.25, while it has fallen to a 52-week low of $57.52. The 50-Day Moving Average of the stock is -4.81%, while the 200-Day Moving Average is calculated to be 2.09%.
Shares Statistics:
The stock has traded on average 3.51M shares per day over the past 3-months and 3291110 shares per day over the last 10 days, according to various share statistics. A total of 392.20M shares are outstanding, with a floating share count of 386.97M. Insiders hold about 1.31% of the company’s shares, while institutions hold 93.94% stake in the company. Shares short for DXCM as of 1752537600 were 8892579 with a Short Ratio of 2.54, compared to 1749772800 on 9375485. Therefore, it implies a Short% of Shares Outstanding of 8892579 and a Short% of Float of 2.91.
